Why Hims and Ro Run Almost Nothing on Their Brand Accounts

The strategic logic behind how category-leading telehealth brands distribute their ad spend — and why brand accounts are rarely the primary performance vehicle at scale.

June 8, 20268 min read

If you search the Meta Ad Library for the largest telehealth brands, you will notice something striking: their official brand accounts are running fewer active ads than you might expect from companies spending heavily on paid social. The bulk of their actual ad volume — the test creative, the high-spend campaigns, the aggressive offers — runs from pages that are not their brand accounts. This pattern is not accidental, and understanding it is one of the more important strategic lessons in telehealth paid social.

Brand Accounts Carry Public Reputational Risk

A telehealth brand's main Facebook and Instagram page is a public-facing asset tied to the company identity. Every ad that runs from that page — every creative test, every offer, every angle — is publicly visible in the Meta Ad Library to competitors, press, regulators, and investors. Brand accounts are transparent in ways that distributed pages are not.

When a test ad fails — when a hook underperforms, when an offer does not land, when an angle turns out to be non-compliant and gets rejected — that event is attached to the brand page's record. A series of rejected ads from a brand page creates a visible compliance history. Competitors can see what you tested. Regulators can pull the library. Journalists can screenshot.

Distributed pages absorb the risk of testing without attaching that risk to the brand identity. Test creative on persona or publisher pages. Scale what works onto brand-adjacent pages. Reserve the brand account for high-confidence, high-quality campaigns that reinforce brand positioning rather than stress-testing creative ideas.

Brand Account Restrictions Have Larger Consequences

When a persona page gets restricted, you lose one distribution point. When your brand account gets restricted, you lose your public identity, your organic reach, your community of followers, and potentially your ability to run any ads until the issue resolves. Brand account restrictions are categorically more damaging than page-level restrictions, and the repair process is more complex.

At the scale of a Hims or a Ro, a brand account restriction does not just affect advertising — it generates press coverage, investor questions, and customer confusion. These companies have built significant brand equity tied to their social media presence. Exposing that to the compliance risk of aggressive performance advertising is not a reasonable trade-off when distributed pages exist as an alternative.

The pattern holds for smaller brands too. Even a mid-stage telehealth brand with modest brand awareness on social should think twice before running all of its ad volume — especially test creative — from its brand page. The brand account is worth protecting. Distributed pages are worth spending to absorb risk.

Distributed Pages Allow More Creative Freedom

Category-leading telehealth brands need to test creative that pushes compliance boundaries — not non-compliant ads, but ads at the edge of what the platform allows, testing how much directness is possible before triggering review. This testing is essential for finding the highest-performing creative angles.

Running these tests from a brand account creates institutional risk aversion. Internal stakeholders become cautious about anything that might get the brand page in trouble. The result is brand account creative that trends toward safe and conservative — precisely the opposite of what performance advertising requires.

Distributed pages solve this by creating a testing environment that is separated from the brand. The creative team can test bold hooks, aggressive offers, and challenging compliance interpretations on persona and publisher pages without triggering institutional caution. This creative freedom is a competitive advantage that is hard to maintain on brand accounts.

We produce paid social creative exclusively for telehealth brands. From 18 to 200 videos per month.

Get in Touch

Scaling Requires More Pages Than a Single Brand Account Can Provide

At significant ad spend, running all campaigns through a single brand account creates delivery constraints. Meta's algorithms optimize differently when an account is serving many campaigns simultaneously, and account-level frequency can become an issue even before audience saturation becomes a problem. Distributing spend across multiple pages gives the algorithm more room to find the right users for each campaign.

Multiple pages running different creative angles and offers essentially allow a brand to be present in the feed through different identities simultaneously. A user might encounter a persona page ad, a publisher page ad, and a brand account ad in the same week — each presenting the telehealth service from a different angle and source identity. This multi-touch presence is harder to achieve when all advertising routes through a single page.

Category leaders like Hims have built page portfolios that run effectively as a media network — multiple pages, multiple identities, multiple angles, all serving the same underlying conversion goal. This is not complexity for its own sake; it is the natural evolution of performance advertising at scale in a category with significant review friction. The case for this approach is laid out in the article on running telehealth ads through multiple pages.

What This Means for Smaller Telehealth Brands

Most smaller telehealth brands cannot replicate the full page infrastructure of a Hims or a Ro. Building and aging multiple pages takes time and operational investment. But the underlying strategic logic applies regardless of scale: protect your brand account, test creative elsewhere, and build distributed infrastructure before you strictly need it.

Start with one persona page in your primary vertical. Age it for 90 days. Begin running proven compliant creative from it at modest budget. Build the operational muscle for managing distributed pages before scaling up. This investment, made early, produces significantly better risk-adjusted outcomes than running everything from your brand account until something goes wrong.

The brands that wait until they have a brand account problem to build distributed infrastructure are always playing catch-up. Building while the brand account is healthy means the distributed pages are aged and ready before they are needed as backup. When you look at how category leaders operate, the planning horizon for distributed page infrastructure is measured in months and years, not days.

Where Brand Accounts Still Belong

This does not mean brand accounts should be abandoned. They serve specific functions that distributed pages cannot replicate. Brand accounts carry organic audiences, brand recognition, and the association with a company identity that users may actively seek out. Campaigns running on brand accounts benefit from users who already know the brand, creating warmer audience interactions.

Brand accounts are appropriate vehicles for high-confidence campaigns with well-tested, clearly compliant creative. They work for brand awareness campaigns, for campaigns targeting existing customers, and for retargeting campaigns directed at users who have already engaged with the brand. These are low-risk use cases where the brand's public identity is a feature, not a liability.

The mature approach is to treat brand accounts and distributed pages as complementary rather than competing. Brand accounts build and reinforce brand equity. Distributed pages absorb creative testing risk, provide additional distribution scale, and run aggressive performance campaigns that would be inappropriate for brand account advertising. The combination is more powerful than either alone, which is why the category leaders maintain both.

We build distributed page infrastructure and brand account strategy for telehealth brands. Page portfolio development, creative distribution strategy, and account protection frameworks for GLP-1, TRT, ED, hair loss, and peptide brands.